Protagonist Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	207.8	434.43	60	26.58	27.36	28.63	Upgrade
Revenue Growth (YoY)	-34.02%	624.05%	125.72%	-2.84%	-4.44%	12293.07%	Upgrade
Gross Profit	207.8	434.43	60	26.58	27.36	28.63	Upgrade
Selling, General & Admin	40.29	43.46	33.49	31.74	27.2	18.64	Upgrade
Research & Development	140.29	138.13	120.16	126.22	126.01	74.51	Upgrade
Operating Expenses	180.58	181.59	153.65	157.95	153.2	93.14	Upgrade
Operating Income	27.22	252.84	-93.65	-131.37	-125.85	-64.52	Upgrade
Interest Expense	-	-	-	-	-	-0.6	Upgrade
Interest & Investment Income	29.51	26.32	14.9	4.06	0.44	0.9	Upgrade
Currency Exchange Gain (Loss)	0.35	0.25	-0.2	-0.08	-0.15	-0.05	Upgrade
EBT Excluding Unusual Items	57.09	279.41	-78.96	-127.39	-125.55	-64.26	Upgrade
Other Unusual Items	-	-	-	-	-	-0.59	Upgrade
Pretax Income	57.09	279.41	-78.96	-127.39	-125.55	-64.85	Upgrade
Income Tax Expense	0.89	4.22	-	-	-	1.31	Upgrade
Net Income	56.19	275.19	-78.96	-127.39	-125.55	-66.15	Upgrade
Net Income to Common	56.19	275.19	-78.96	-127.39	-125.55	-66.15	Upgrade
Shares Outstanding (Basic)	62	62	57	49	46	34	Upgrade
Shares Outstanding (Diluted)	65	65	57	49	46	34	Upgrade
Shares Change (YoY)	8.17%	14.65%	15.74%	5.87%	34.67%	32.84%	Upgrade
EPS (Basic)	0.90	4.47	-1.39	-2.60	-2.71	-1.92	Upgrade
EPS (Diluted)	0.86	4.23	-1.39	-2.60	-2.71	-1.92	Upgrade
Free Cash Flow	335.29	182.8	-70.85	-108.93	-108.97	-72.96	Upgrade
Free Cash Flow Per Share	5.17	2.81	-1.25	-2.22	-2.35	-2.12	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	13.10%	58.20%	-156.09%	-494.24%	-460.01%	-225.36%	Upgrade
Profit Margin	27.04%	63.34%	-131.59%	-479.26%	-458.94%	-231.07%	Upgrade
Free Cash Flow Margin	161.35%	42.08%	-118.08%	-409.81%	-398.31%	-254.84%	Upgrade
EBITDA	28.05	253.67	-92.68	-130.34	-125.03	-63.57	Upgrade
EBITDA Margin	13.50%	58.39%	-154.46%	-	-	-222.05%	Upgrade
D&A For EBITDA	0.83	0.83	0.98	1.03	0.81	0.95	Upgrade
EBIT	27.22	252.84	-93.65	-131.37	-125.85	-64.52	Upgrade
EBIT Margin	13.10%	58.20%	-156.09%	-	-	-225.36%	Upgrade
Effective Tax Rate	1.57%	1.51%	-	-	-	-	Upgrade

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q